EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Emicizumab PUPs and Nuwiq ITI Study

Phase 3

Withdrawn

Conditions: Hemophilia A

Interventions: Drug: HEMLIBRA
Drug: Nuwiq (low dose protocol)
Drug: Nuwiq (Atlanta protocol)

First Posted Date: 2019-07-23

Last Posted Date: 2024-01-05

Lead Sponsor: Emory University

Registration Number: NCT04030052

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States

and more 5 locations

Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease

Not Applicable

Recruiting

Conditions: Prodromal Alzheimer's Disease

Interventions: Other: Group walking (WALK)
Other: Partnered Rhythmic Rehabilitation (PRR)

First Posted Date: 2019-07-23

Last Posted Date: 2024-04-30

Lead Sponsor: Emory University

Target Recruit Count: 66

Registration Number: NCT04029623

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

Clarithromycin Mechanisms in Hypersomnia Syndromes

Phase 2

Recruiting

Conditions: Narcolepsy Without Cataplexy
Idiopathic Hypersomnia
Narcolepsy With Cataplexy

Interventions: Drug: Placebo
Drug: Clarithromycin

First Posted Date: 2019-07-19

Last Posted Date: 2024-06-20

Lead Sponsor: Emory University

Target Recruit Count: 92

Registration Number: NCT04026958

Locations: 🇺🇸
Emory Sleep Center, Atlanta, Georgia, United States

Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer

Phase 2

Active, not recruiting

Conditions: Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma
Stage III Renal Cell Cancer AJCC v8

Interventions: Drug: Cabozantinib

First Posted Date: 2019-07-17

Last Posted Date: 2024-08-13

Lead Sponsor: Emory University

Target Recruit Count: 22

Registration Number: NCT04022343

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Treatment of Hemophilia A Patients With FVIII Inhibitors

Recruiting

Conditions: Hemophilia A

Interventions: Biological: Nuwiq
Biological: Octanate
Biological: Wilate
Biological: Recombinant factor VIIa (rFVIIa)
Biological: Emicizumab
Biological: Activated prothrombin complex concentrate (aPCC)

First Posted Date: 2019-07-17

Last Posted Date: 2024-08-26

Lead Sponsor: Emory University

Target Recruit Count: 120

Registration Number: NCT04023019

Locations: 🇩🇪
HZRM Hämophilie-Zentrum Rhein Main, Morfelden-Walldorf, Germany
🇺🇸
Arthur M. Blank Hospital, Atlanta, Georgia, United States

Feasibility of EnChroma Use in the Emergency Department Setting

Not Applicable

Terminated

Conditions: Color Vision Defects

Interventions: Device: EnChroma glasses

First Posted Date: 2019-07-16

Last Posted Date: 2023-09-18

Lead Sponsor: Emory University

Target Recruit Count: 6

Registration Number: NCT04021914

Locations: 🇺🇸
Emory Hospital, Atlanta, Georgia, United States

Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation

Phase 2

Active, not recruiting

Conditions: Sickle Cell Disease

Interventions: Drug: Alemtuzumab
Drug: Fludarabine
Drug: Melphalan

First Posted Date: 2019-07-15

Last Posted Date: 2024-11-25

Lead Sponsor: Emory University

Target Recruit Count: 43

Registration Number: NCT04018937

Locations: 🇺🇸
Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸
Phoenix Children's, Phoenix, Arizona, United States
🇺🇸
Yale University, Yale Cancer Center, New Haven, Connecticut, United States

and more 12 locations

Preventing Early Child Marriage in Nepal

Not Applicable

Completed

Conditions: Child Marriage

Interventions: Behavioral: Full TP intervention
Behavioral: Light TP intervention

First Posted Date: 2019-07-11

Last Posted Date: 2022-02-17

Lead Sponsor: Emory University

Target Recruit Count: 2828

Registration Number: NCT04015856

Locations: 🇳🇵
Interdisciplinary Analysts, Kathmandu, Nepal

Innovative Biofeedback Interface for Enhancing Stroke Gait Rehabilitation

Not Applicable

Completed

Conditions: Gait, Hemiplegic
Stroke

Interventions: Other: AGRF Biofeedback Game
Other: Optional Game with VR
Other: Traditional Biofeedback Interface
Other: Control Condition

First Posted Date: 2019-07-10

Last Posted Date: 2024-11-04

Lead Sponsor: Emory University

Target Recruit Count: 19

Registration Number: NCT04013971

Locations: 🇺🇸
Emory Rehabilitation Hospital, Atlanta, Georgia, United States

Emory Teaching Kitchen Collaborative

Not Applicable

Completed

Conditions: Healthy Lifestyle

Interventions: Behavioral: Teaching kitchen program

First Posted Date: 2019-07-02

Last Posted Date: 2021-10-20

Lead Sponsor: Emory University

Target Recruit Count: 41

Registration Number: NCT04005495

Locations: 🇺🇸
Emory Clinic, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy